Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 19/20 | 0.78 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 0.78 |
| ▸ | MMP3 | P08254 | 2/20 | 0.78 |
| ▸ | MMP7 | P09237 | 2/20 | 0.78 |
| ▸ | ADAMTS1 | Q9UHI8 | 2/20 | 0.78 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.78 |
| ▸ | MMP8 | P22894 | 1/20 | 0.67 |
| ▸ | MMP13 | P45452 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6597542 | 0.91 | ADAM17 (0.71) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| SCHEMBL6599983 | 0.88 | ADAM17 (1.00) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| SCHEMBL6597320 | 0.88 | ADAM17 (1.00) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| SCHEMBL6597759 | 0.88 | ADAM17 (1.00) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| SCHEMBL6595027 | 0.88 | ADAM17 (0.98) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| Trifluoroacetic Acid SCHEMBL6597061 | 0.87 | ADAM17 (0.66) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| SCHEMBL6597835 | 0.87 | ADAM17 (0.67) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| SCHEMBL6600065 | 0.86 | ADAM17 (0.95) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| SCHEMBL6594466 | 0.85 | ADAM17 (0.83) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 | |
| SCHEMBL6595495 | 0.85 | ADAM17 (0.83) | ADAM17ADAMTS4MMP3MMP7ADAMTS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1263756-A2 | BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA | Bristol-Myers Squibb Pharma Company (US) | 2002-12-11 | — | — | EP | claimed |
| WO-2001070734-A2 | BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-09-27 | — | — | WO | claimed |